{
    "organizations": [],
    "uuid": "dabc1a3dcb3dfec044d4926b7953a0561b13a403",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ceo-says-bristol-myers-still-a-gro/brief-ceo-says-bristol-myers-still-a-growth-company-idUSL1N1S317Z",
    "ord_in_thread": 0,
    "title": "CEO Says Bristol-Myers Still A Growth Company",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Bristol-Myers Squibb Co:\n* BRISTOL-MYERS SQUIBB SEES CONTINUED GROWTH IN ANTICOAGULANT MARKET SHARE FOR ELIQUIS\n* BRISTOL-MYERS CEO SAYS CONTINUES TO SEE BMS AS A GROWTH COMPANY AND OPDIVO AS A GROWTH FRANCHISE Source text for Eikon: (Reporting By Bill Berkrot)\n ",
    "published": "2018-04-26T23:40:00.000+03:00",
    "crawled": "2018-04-27T16:24:46.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "squibb",
        "co",
        "squibb",
        "see",
        "continued",
        "growth",
        "anticoagulant",
        "market",
        "share",
        "eliquis",
        "ceo",
        "say",
        "continues",
        "see",
        "bm",
        "growth",
        "company",
        "opdivo",
        "growth",
        "franchise",
        "source",
        "text",
        "eikon",
        "reporting",
        "bill",
        "berkrot"
    ]
}